High-throughput Combination Screening
High-Throughput Combination Screening is a systematic experimental methodology that enables the rapid, parallel assessment of numerous drug combinations to identify synergistic interactions, distinguished by its scalable automation and quantitative analysis in drug repurposing research.
75
Publications
7.8K
Citations
508
Authors
162
Institutions
Publications per year
2017–2026
47
75
An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies
Jennifer O’Neil, Yair Benita, Igor Feldman et al. · Molecular Cancer Therapeutics · 2016 · 432 citations
Medicine, Oncology, Pharmacology +13
Lesley A. Mathews Griner, Rajarshi Guha, Paul Shinn et al. · Proceedings of the National Academy of Sciences · 2014 · 397 citations · Full text
Medicine, Oncology, Pharmacology +14
1–5 of 75
508
5
h-index
3
h-index
3
h-index
3
h-index
National Center for Advancing Translational Sciences, United States
3 publications · 443 citations
3
h-index
1–5 of 508
162
Center for Cancer Research
Bethesda, United States
6 h-index
18 publications
1.2K citations

University of Helsinki
Helsinki, Finland
6 h-index
40 publications
9.2K citations
Institute for Molecular Medicine Finland
Helsinki, Finland
6 h-index
40 publications
9.2K citations
National Center for Advancing Translational Sciences
Rockville, United States
5 h-index
51 publications
11.6K citations

Broad Institute
Cambridge, United States
5 h-index
12 publications
1.3K citations
Harvard University
Cambridge, United States
5 h-index
18 publications
1.5K citations
National Cancer Institute
Bethesda, United States
4 h-index
13 publications
643 citations

University of Turku
Turku, Finland
3 h-index
5 publications
594 citations
1–8 of 162
PNAS · 5 publications · 1.4K citations
5
h-index
Repository · 3 publications · 83 citations
3
h-index
3 publications · 790 citations
3
h-index
MCT · 3 publications · 488 citations
3
h-index
3 publications · 81 citations
3
h-index
1–5